Ronald Lizée
Financieel Directeur/CFO bij Acrongenomics, Inc.
Profiel
Ronald Lizée is currently the President & Chief Executive Officer at Gemstar Capital Properties, Inc. He is also the Chief Financial Officer at Acrongenomics, Inc. Previously, he served as the Chief Financial Officer, Treasurer & Director at PreAxia Health Care Payment Systems, Inc. from 2008 to 2011.
Additionally, he was the Chief Financial Officer at Sun World Partners, Inc. from 2008 to 2009.
Mr. Lizée obtained his undergraduate degree from the University of Saskatchewan in 1981.
Actieve functies van Ronald Lizée
| Bedrijven | Functie | Begin |
|---|---|---|
Acrongenomics, Inc.
 Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Financieel Directeur/CFO | 04-06-2004 |
| Gemstar Capital Properties, Inc. | Algemeen Directeur | 02-03-2010 |
Eerdere bekende functies van Ronald Lizée
| Bedrijven | Functie | Einde |
|---|---|---|
| PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. | Financieel Directeur/CFO | 24-11-2011 |
| Sun World Partners, Inc. | Financieel Directeur/CFO | 15-01-2009 |
Opleiding van Ronald Lizée
| University of Saskatchewan | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. | Technology Services |
| Bedrijven in privébezit | 3 |
|---|---|
Acrongenomics, Inc.
Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
| Sun World Partners, Inc. | Retail Trade |
| Gemstar Capital Properties, Inc. |
